Research and Development
Most recent publications
Penedones A, Mendes D, Alves C, Filipe A, Oliveira T, Batel-Marques F. Relationship Between Chronic Obstructive Pulmonary Disease and Osteoporosis: A Scoping Review. Copd. 2024;21(1):2356510. https://doi.org/10.1080/15412555.2024.2356510
Mendes D, Figueiredo D, Alves C, Penedones A, Costa B, Batel-Marques F. Impact of the COVID-19 pandemic on cancer screenings in Portugal. Cancer Epidemiol. 2024;88:102496. https://doi.org/10.1016/j.canep.2023.102496
Alves C, Mendes D, Penedones A, Oliveira T, Donato A, Batel-Marques F. The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies. Int J Clin Pharm. 2024;46(2):357-67. https://doi.org/10.1007/s11096-023-01666-x
Mendes D, Penedones A, Alves C, Oliveira T, Donato A, Batel-Marques F. Ibandronate in the Prevention of Vertebral and Nonvertebral Osteoporotic Fractures: A Systematic Review of Experimental and Observational Studies. J Clin Rheumatol. 2023;29(2):78-83. https://doi.org/10.1097/RHU.0000000000001902
Alves C, Penedones A, Mendes D, Batel Marques F. Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis. Int J Clin Pharm. 2023;45(4):830-8. https://doi.org/10.1007/s11096-023-01569-x
Most recent communications
Mendes D, Figueiredo D, Alves C, et al. EPH80 Impact of the COVID-19 Pandemic on Arterial Hypertension Monitoring and Control in Portugal. Value in Health. 2024;27(12):S236-S237. https://doi.org/10.1016/j.jval.2024.10.1210
Costa B, Alves C, Mendes D, et al. CO51 Second-Line Pharmacological Interventions for Advanced Non-Small Cell Lung Cancer in MetEX14 Skipping Patients: A Systematic Literature Review. Value in Health. 2024;27(12):S24. https://doi.org/10.1016/j.jval.2024.10.128
Sousa A, Alves C, Batel Marques F, Mendes D. HTA178 The Health Technology Assessment System in Portugal: A Study on Medicines Reimbursement Recommendations. Value in Health. 2024;27(12):S389. https://doi.org/10.1016/j.jval.2024.10.2003
Nobrega E, Alves C, Batel Marques F, Mendes D. HTA177 Reasons for Drug Market Access Failure in Portugal: A Retrospective Analysis of Public Reimbursement Reports. Value in Health. 2024;27(12):S388. https://doi.org/10.1016/j.jval.2024.10.2002
Matos P, Mendes D, Batel Marques F, Alves C. HTA170 Use of Off-Label Comparators in Health Technonology Assessment in Portugal: A Review of Reimbursement Appraisal Reports. Value in Health. 2024;27(12):S387. https://doi.org/10.1016/j.jval.2024.10.1995
Mendes D, Figueiredo D, Alves C, et al. EPH79 Impact of the COVID-19 Pandemic on Diabetes Mellitus Care in Portugal. Value in Health. 2024;27(12):S236. https://doi.org/10.1016/j.jval.2024.10.1209
Alves C, Penedones A, Mendes D, Batel Marques F. EPH8 Risk of Acute Pancreatitis Associated With ARBs and ACE Inhibitors: A Meta-Analysis of Observational Studies. Value in Health. 2024;27(12):S224. https://doi.org/10.1016/j.jval.2024.10.1140
Mendes D, Figueiredo D, Alves C, et al. P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses. Value in Health. 2023;26(12):S2-S3. https://doi.org/10.1016/j.jval.2023.09.012
Ribeiro C, Penedones A, Mendes D, Alves C. HTA338 Characterization of the Evidence Supporting the Relative Effectiveness Evaluations in Health Technologies Assessment: A Review. Value in Health. 2023;26(12):S385. https://doi.org/10.1016/j.jval.2023.09.2021
Ribeiro C, Penedones A, Mendes D, Alves C. HTA46 Relationship Between the Directness of the Evidence and Identification of Added Therapeutic Value: An Analysis of HTA Procedures. Value in Health. 2023;26(12):S328-S329. https://doi.org/10.1016/j.jval.2023.09.1731
